CAMBRIDGE, Mass. & NEW ORLEANS--(BUSINESS WIRE)--Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, ...
US-based neurotechnology company Cognito Therapeutics has collaborated with Ochsner Health to establish the Brain Health Collaboratory, aiming to advance new care models for cognitive decline and ...
Cognito Therapeutics Partners with Initiative to Change the "D-Word," Commits to Eliminating Use of "Dementia" Across All Communications ...
“If you can drive the brain's naturally occurring activity, what you can get is the biologic expression that is important for brains to maintain and protect themselves.,” CEO Christian Howell explains ...
Cognito Therapeutics and the West Virginia University Rockefeller Neuroscience Institute (RNI), announced today the launch of the first Brain Health Collaboratory, a new model designed to accelerate ...
Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics announced a $105 million Series C round ...
Collaboration expands national initiative designed to accelerate the discovery, validation, and delivery of non-invasive neuroprotective therapies Cognito Therapeutics, a late clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results